Profile data is unavailable for this security.
About the company
OncoTherapy Science, Inc. is a Japan-based company mainly engaged in the development of drugs. The Company is involved in the development of low molecular drugs, antibody drugs and other drugs, as well as the provision and clinical development of medical candidate substances. The Company operates its business in cooperation with universities and other corporations. The Company provides its licenses to pharmaceutical manufacturers. The Company also involves in T Cell Receptor(TCR) analysis business.
- Revenue in JPY (TTM)478.75m
- Net income in JPY-1.12bn
- Incorporated2001
- Employees54.00
- LocationOncoTherapy Science Inc1-2, Higashida-cho, Kawasaki-kuKAWASAKI-SHI 210-0005JapanJPN
- Phone+81 442016429
- Fax+81 442016473
- Websitehttps://www.oncotherapy.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kidswell Bio Corp | 3.60bn | -883.62m | 4.63bn | 42.00 | -- | 5.41 | -- | 1.29 | -22.78 | -22.78 | 92.26 | 21.08 | 0.9182 | 2.73 | 6.63 | 85,697,070.00 | -22.54 | -57.41 | -35.96 | -81.13 | 36.17 | 55.20 | -24.55 | -123.52 | 1.64 | -17.95 | 0.7132 | -- | -12.43 | 18.93 | -116.31 | -- | -- | -- |
| DNA Chip Research Inc | 766.32m | -118.13m | 4.73bn | 37.00 | -- | 6.74 | -- | 6.17 | -18.29 | -18.29 | 116.80 | 103.64 | 0.9159 | 8.50 | 7.86 | 20,711,350.00 | -14.12 | -23.49 | -17.74 | -26.70 | 38.52 | 14.28 | -15.41 | -54.10 | 2.78 | -641.51 | 0.00 | -- | 49.74 | 6.33 | 31.48 | -- | -15.75 | -- |
| Carna Biosciences, Inc. | 1.40bn | -1.51bn | 5.52bn | 67.00 | -- | 1.96 | -- | 3.94 | -85.98 | -85.98 | 80.34 | 147.09 | 0.391 | 1.19 | 13.59 | 20,922,580.00 | -42.15 | -14.45 | -45.45 | -16.95 | 87.53 | 90.59 | -107.80 | -35.42 | 11.11 | -- | 0.0215 | -- | 17.24 | 16.59 | 14.57 | -- | -27.69 | -- |
| Veritas In Silico Inc | 246.24m | -148.31m | 5.85bn | 15.00 | -- | 2.54 | -- | 23.76 | -23.92 | -23.92 | 38.93 | 354.61 | 0.1227 | -- | -- | 16,415,930.00 | -7.39 | -- | -7.65 | -- | -- | -- | -60.23 | -- | 67.03 | -- | -- | -- | 101.54 | -- | 123.38 | -- | -- | -- |
| Kringle Pharma Inc | 80.04m | -756.45m | 6.00bn | 13.00 | -- | 2.85 | -- | 74.97 | -118.21 | -118.21 | 12.71 | 309.55 | 0.0298 | -- | 1.15 | -- | -28.14 | -19.17 | -30.03 | -20.40 | -- | -- | -945.12 | -181.86 | 19.20 | -- | -- | -- | 15.58 | -- | 11.44 | -- | -- | -- |
| Chiome Bioscience Inc | 581.07m | -1.22bn | 6.24bn | 51.00 | -- | 5.04 | -- | 10.75 | -22.07 | -22.07 | 10.53 | 19.85 | 0.3371 | 5.16 | 8.01 | 11,393,550.00 | -70.61 | -50.50 | -95.97 | -57.38 | 53.55 | 57.53 | -209.45 | -224.74 | 3.57 | -894.37 | 0.1995 | -- | 8.19 | 26.24 | 1.84 | -- | -- | -- |
| Noile-Immune Biotech Inc | 8.12m | -1.07bn | 7.01bn | 28.00 | -- | 1.43 | -- | 864.12 | -24.64 | -24.64 | 0.1875 | 113.23 | 0.0015 | 0.0229 | 0.0283 | 289,928.60 | -19.15 | -- | -19.61 | -- | 95.58 | -- | -13,139.53 | -- | 79.60 | -- | -- | -- | -49.37 | -- | -192.28 | -- | -- | -- |
| OncoTherapy Science, Inc. | 478.75m | -1.12bn | 8.42bn | 54.00 | -- | 8.42 | -- | 17.59 | -4.86 | -4.86 | 2.04 | 3.68 | 0.3526 | 4.34 | 9.77 | 8,865,722.00 | -82.71 | -55.67 | -106.53 | -63.82 | -32.12 | -1.49 | -234.61 | -247.47 | 3.11 | -- | 0.0731 | -- | -46.24 | 16.81 | -15.15 | -- | -48.33 | -- |
| TMS Co Ltd | 0.00 | -1.10bn | 8.47bn | 14.00 | -- | 2.83 | -- | -- | -28.37 | -28.37 | 0.00 | 74.10 | 0.00 | -- | -- | 0.00 | -33.57 | -- | -34.42 | -- | -- | -- | -- | -- | 31.13 | -- | 0.00 | -- | -- | -- | -11.51 | -- | -- | -- |
| Linical Co Ltd | 11.67bn | -121.16m | 8.51bn | 662.00 | -- | 1.05 | 20.71 | 0.7293 | -5.36 | -5.36 | 516.67 | 326.90 | 0.6575 | -- | 3.74 | 17,628,030.00 | -0.6826 | 4.01 | -1.18 | 6.33 | 26.63 | 30.99 | -1.04 | 5.48 | -- | 2.65 | 0.2588 | 50.81 | -1.67 | 1.70 | -66.32 | -9.86 | -10.18 | 4.56 |
| Modalis Therapeutics Corp | 0.00 | -1.87bn | 9.09bn | 37.00 | -- | 2.95 | -- | -- | -52.79 | -52.79 | 0.00 | 44.35 | 0.00 | -- | -- | 0.00 | -74.95 | -29.19 | -78.46 | -30.02 | -- | -- | -- | -597.35 | 43.87 | -87.46 | 0.0771 | -- | -100.00 | -- | 11.50 | -- | 135.50 | -- |
| Medinet Co Ltd | 768.50m | -1.28bn | 10.58bn | 98.00 | -- | 2.04 | -- | 13.77 | -5.04 | -5.04 | 3.05 | 19.62 | 0.1356 | 11.15 | 3.46 | -- | -22.53 | -21.15 | -23.83 | -22.39 | 14.66 | 22.97 | -166.17 | -160.19 | 18.45 | -- | 0.0002 | -- | 16.17 | -6.21 | 11.19 | -- | -11.16 | -- |
| Tsubota Laboratory Inc | 1.11bn | -303.08m | 10.87bn | 7.00 | -- | 7.70 | -- | 9.78 | -12.09 | -12.09 | 43.15 | 55.21 | 0.4899 | 1.60 | 5.16 | 158,704,300.00 | -13.37 | -- | -18.33 | -- | 52.59 | -- | -27.28 | -- | 2.57 | -24.64 | 0.0678 | -- | -29.45 | -- | -811.14 | -- | -- | -- |
| 3-D Matrix Ltd | 5.25bn | -1.05bn | 11.06bn | 106.00 | -- | 9.52 | -- | 2.11 | -12.89 | -12.89 | 66.88 | 11.66 | 0.8559 | 0.551 | 5.40 | 49,502,420.00 | -17.15 | -42.10 | -21.31 | -55.60 | 68.38 | 53.95 | -20.04 | -96.03 | 2.51 | -- | 0.7979 | -- | 98.30 | 69.41 | 89.55 | -- | -30.34 | -- |
| PRISM BioLab Co Ltd | -100.00bn | -100.00bn | 11.65bn | 22.00 | -- | 5.51 | -- | -- | -- | -- | -- | 58.79 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -79.63 | -- | -822.18 | -- | -- | -- |
| Nano Mrna Co Ltd | 52.10m | -821.00m | 11.65bn | 18.00 | -- | 3.81 | -- | 223.67 | -11.66 | -11.66 | 0.74 | 43.30 | 0.0102 | 7.01 | 1.56 | 2,894,445.00 | -16.13 | -24.16 | -17.89 | -25.17 | 80.72 | 84.69 | -1,575.81 | -600.70 | 8.17 | -- | 0.2662 | -- | -32.98 | -22.88 | 40.50 | -- | -- | -- |
Data as of Nov 22 2024. Currency figures normalised to OncoTherapy Science Inc's reporting currency: Japanese Yen JPY
1.15%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Long Corridor Asset Management Ltd.as of 12 Jul 2024 | 2.00m | 0.74% |
| Simplex Asset Management Co., Ltd.as of 07 Nov 2024 | 1.14m | 0.42% |
Data from 30 Sep 2024 - 14 Nov 2024Source: FactSet Research Systems Inc.
